TH and cardiac hypertrophy: The second pathway was the thyroid hormone (TH) signaling pathway, including only MED13. MED13 was the major target of microRNA-208, which was specific to cardiac muscle, and modulated the activity of the thyroid hormone receptor related to cardiac hypertrophy.